Document is current

Article History

Received: 27 March 2023

Accepted: 4 September 2023

First Online: 30 September 2023

Declarations

:

: Ethical Committees from all five university hospitals (Helsinki University Hospital, Tampere University Hospital, Turku University Hospital, Kuopio University Hospital and Oulu University Hospital) in Finland have given their approval for the FinnishIPF project. The National Institute of Health and Welfare has given authorization for patient screening from the hospital databases of all Finnish hospitals. All included patients have given their written informed consent. Data are stored in a secure electronic database. Only responsible doctors and educated study nurses can access the registry with electronic identity verification.All experiments were performed in accordance with Declaration of Helsinki.

: Not applicable.

: J. Kaunisto reports the following relationships outside the submitted work: lecture fees from Boehringer Ingelheim; support for attending meetings and/or travel from Boehringer Ingelheim, Roche and GlaxoSmithKline. E-R Salomaa has nothing to disclose. M. Koivisto has nothing to disclose. M. Myllärniemi has worked as national principal investigator in several studies related to IPF, including Roche and Boehringer Ingelheim and MSD. She has not received personal fees for these studies, all funding and research agreements have been processed through the Helsinki University Hospital Institution HUCH institute. She has no conflicts of interest from these studies that would affect the rationale or conclusions of the current study.